|
111 |
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen Enthalten in Journal of neurology Bd. 272, 14.3.2025, Nr. 4, date:4.2025: 1-17
|
|
|
112 |
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients Enthalten in Journal of neuro-oncology Bd. 145, 2.11.2019, Nr. 3, date:12.2019: 531-540
|
|
|
113 |
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence Enthalten in Acta neuropathologica Bd. 135, 7.4.2018, Nr. 6, date:6.2018: 955-963
|
|
|
114 |
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma Enthalten in Acta neuropathologica Bd. 148, 8.8.2024, Nr. 1, date:12.2024: 1-4
|
|
|
115 |
Meningeosis neoplastica Enthalten in Info Neurologie & Psychiatrie Bd. 18, 26.9.2016, Nr. 9, date:9.2016: 40-50
|
|
|
116 |
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma Enthalten in Acta neuropathologica Bd. 138, 8.5.2019, Nr. 2, date:8.2019: 295-308
|
|
|
117 |
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study Enthalten in Journal of neuro-oncology Bd. 148, 4.5.2020, Nr. 1, date:5.2020: 117-130
|
|
|
118 |
Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients Enthalten in Quality of life research Bd. 31, 18.8.2022, Nr. 11, date:11.2022: 3253-3266
|
|
|
119 |
New glioblastoma heterogeneity atlas — a shared resource Enthalten in Nature reviews / Neurology Bd. 14, 26.6.2018, Nr. 8, date:8.2018: 453-454
|
|
|
120 |
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets Enthalten in Acta neuropathologica Bd. 131, 15.12.2015, Nr. 6, date:6.2016: 903-910
|
|